Vivos Therapeutics (VVOS) Preferred Dividend Payments (2020)

Vivos Therapeutics (VVOS) reported Preferred Dividend Payments of $1.6 million for Q4 2020, up 533.2% quarter-over-quarter from $250000.0 in Q3 2020.

Vivos Therapeutics (VVOS) Preferred Dividend Payments (2020) Analysis & Trends

Vivos Therapeutics (VVOS) has 1 years of Preferred Dividend Payments data on file, last reported at $1.6 million in Q4 2020.

Preferred Dividend Payments for Q4 2020 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $2.3 million (changed N/A YoY), and the FY2020 annual result was $2.3 million, up 133.3% from the prior year.
Preferred Dividend Payments advanced to $1.6 million in Q4 2020 per VVOS's latest filing, from $250000.0 in the prior quarter.
Over five years, Preferred Dividend Payments peaked at $1.6 million in Q4 2020 and troughed at $250000.0 in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Vivos Therapeutics	7.39 Mn	5.16 Mn	3.06 Mn	-

Download Data